[Federal Register Volume 72, Number 221 (Friday, November 16, 2007)]
[Notices]
[Page 64672]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-22512]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated July 31, 2007 and published in the Federal Register 
on August 9, 2007, (72 FR 44859), Almac Clinical Services Inc., (ACSI), 
2661 Audubon Road, Audubon, Pennsylvania 19403, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of the basic classes of controlled substances listed in 
schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances in dosage form to conduct clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Almac Clinical Services Inc. to import the basic 
classes of controlled substances is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. DEA 
has investigated Almac Clinical Services Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic classes of controlled 
substances listed.

    Dated: November 6, 2007.
Joseph T. Rannazzisi,
Deputy Assistant, Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-22512 Filed 11-15-07; 8:45 am]
BILLING CODE 4410-09-P